Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Medical treatment of Cushing's disease.

Feelders RA, Hofland LJ.

J Clin Endocrinol Metab. 2013 Feb;98(2):425-38. doi: 10.1210/jc.2012-3126. Epub 2013 Jan 23. Review.

PMID:
23345100
2.

Cushing's disease: current medical therapies and molecular insights guiding future therapies.

Lau D, Rutledge C, Aghi MK.

Neurosurg Focus. 2015 Feb;38(2):E11. doi: 10.3171/2014.10.FOCUS14700. Review.

PMID:
25639313
3.

Medical management of Cushing's disease: what is the future?

Fleseriu M, Petersenn S.

Pituitary. 2012 Sep;15(3):330-41. doi: 10.1007/s11102-012-0397-5. Review.

4.

The Treatment of Cushing's Disease.

Pivonello R, De Leo M, Cozzolino A, Colao A.

Endocr Rev. 2015 Aug;36(4):385-486. doi: 10.1210/er.2013-1048. Epub 2015 Jun 11. Review.

5.

Medical therapy of Cushing's disease: where are we now?

Alexandraki KI, Grossman AB.

Front Horm Res. 2010;38:165-73. doi: 10.1159/000318507. Epub 2010 Jul 5. Review.

PMID:
20616508
6.

Medical treatment of Cushing's disease: somatostatin analogues and pasireotide.

Pedroncelli AM.

Neuroendocrinology. 2010;92 Suppl 1:120-4. doi: 10.1159/000314352. Epub 2010 Sep 10. Review.

7.

Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.

Fleseriu M, Petersenn S.

Pituitary. 2015 Apr;18(2):245-52. doi: 10.1007/s11102-014-0627-0. Review.

PMID:
25560275
8.

Treatment of Cushing's disease: a mechanistic update.

Cuevas-Ramos D, Fleseriu M.

J Endocrinol. 2014 Nov;223(2):R19-39. doi: 10.1530/JOE-14-0300. Epub 2014 Aug 18. Review.

9.

Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.

Feelders RA, Hofland LJ, de Herder WW.

Neuroendocrinology. 2010;92 Suppl 1:111-5. doi: 10.1159/000314292. Epub 2010 Sep 10. Review.

10.

Somatostatin and somatostatin receptors in Cushing's disease.

Hofland LJ.

Mol Cell Endocrinol. 2008 May 14;286(1-2):199-205. doi: 10.1016/j.mce.2007.10.015. Epub 2007 Nov 22. Review.

PMID:
18221833
11.

Update in the medical therapy of Cushing's disease.

Nieman LK.

Curr Opin Endocrinol Diabetes Obes. 2013 Aug;20(4):330-4. doi: 10.1097/MED.0b013e3283631809. Review.

12.

New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.

Fleseriu M, Petersenn S.

J Neurooncol. 2013 Aug;114(1):1-11. doi: 10.1007/s11060-013-1151-1. Epub 2013 May 15. Review.

13.

Pituitary-targeted medical therapy of Cushing's disease.

Alexandraki KI, Grossman AB.

Expert Opin Investig Drugs. 2008 May;17(5):669-77. doi: 10.1517/13543784.17.5.669 . Review. Erratum in: Expert Opin Investig Drugs. 2008 Jul;17(7):1141.

PMID:
18447593
14.

Current approaches to the pharmacological management of Cushing's disease.

Molitch ME.

Mol Cell Endocrinol. 2015 Jun 15;408:185-9. doi: 10.1016/j.mce.2014.09.021. Epub 2014 Oct 29. Review.

PMID:
25450859
15.

The role of somatostatin analogs in Cushing's disease.

van der Hoek J, Lamberts SW, Hofland LJ.

Pituitary. 2004;7(4):257-64. Review.

PMID:
16132202
16.

Pasireotide and mifepristone: new options in the medical management of Cushing's disease.

Cohan P.

Endocr Pract. 2014 Jan;20(1):84-93. doi: 10.4158/EP13127.RA. Review.

PMID:
24126229
17.

Pasireotide (SOM230): development, mechanism of action and potential applications.

Schmid HA.

Mol Cell Endocrinol. 2008 May 14;286(1-2):69-74. Epub 2007 Sep 19. Review.

PMID:
17977644
18.

Medical management of Cushing's disease.

Tritos NA, Biller BM.

J Neurooncol. 2014 May;117(3):407-14. doi: 10.1007/s11060-013-1269-1. Epub 2013 Oct 22. Review.

PMID:
24146187
19.

Future treatment strategies of aggressive pituitary tumors.

Lamberts SW, Hofland LJ.

Pituitary. 2009;12(3):261-4. doi: 10.1007/s11102-008-0154-y. Review.

20.

Efficacy of medical treatment in Cushing's disease: a systematic review.

Gadelha MR, Vieira Neto L.

Clin Endocrinol (Oxf). 2014 Jan;80(1):1-12. doi: 10.1111/cen.12345. Epub 2013 Nov 12. Review.

PMID:
24118077

Supplemental Content

Support Center